Braunschweig, January 10, 2023 – On December 8, 2022, YUMAB’s founders and team celebrated the company’s 10th anniversary together with partners from business, politics, and science at the company’s site in Braunschweig. What began as an academic start-up with the mission to facilitate biomedical translation is now a globally operating biotech company and a trusted service partner for therapeutic antibody development.
Read press release (German)
Visit our anniversary page and enjoy lots of entertaining facts, stories and images that document YUMAB’s journey over the past decade.
Dr. Thomas Schirrmann, CEO
Phone: +49-531 481170-0